A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Study Identifier
P11-282
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Recruitment Complete
Sign up for trial alerts

Study Details

Medical Condition
  • Ulcerative Colitis (UC)
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18 - 99 Years

    Protocol Summary

    This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.

    Study Locations

    Location
    Status
    Location
    Birmingham Gastroenterology Associates P.C /ID# 102063
    Birmingham, Alabama, United States, 35209
    Status
    Not applicable
    Location
    University of Alabama at Birmingham - Main /ID# 131646
    Birmingham, Alabama, United States, 35233
    Status
    Not applicable
    Location
    Longwood Research /ID# 118662
    Huntsville, Alabama, United States, 35801
    Status
    Not applicable
    Location
    East View Medical Research, LLC /ID# 116259
    Mobile, Alabama, United States, 36606
    Status
    Not applicable
    Location
    Mobile Medical & Diagnostic Center, AL /ID# 102064
    Mobile, Alabama, United States, 36617
    Status
    Not applicable
    Location
    HOPE Research Institute /ID# 127947
    Phoenix, Arizona, United States, 85018
    Status
    Not applicable
    Showing {first} - {last} of {total} Results